Home Research COVID-19 Services Publications People Teaching Job Opening News Forum --> -->
Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●DMFold ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

BioLiP
Download all results in tab-seperated text for 56 receptor-ligand interactions, whose format is explained at readme.txt.
  • Hover over PDB to view the title of the structure. Click PDB to view the structure at the RCSB PDB database. Resolution -1.00 means the resolution is unavailable, e.g., for NMR structures.
  • Click Site # to view the binding site structure. Hover over Site # to view the binding residues.
  • Hover over Ligand to view the full ligand name. Click Ligand to view the 2D diagram and other detail information of the ligand.
  • Hover over EC number to view the full name of enzymatic activity.
  • Hover over GO terms to view all GO terms.
  • Hover over UniProt to view the protein name.

    • Sort results by
    << < 1 > >>
    Go to page

    # PDB
    (Resolution Å)     		Site # Ligand EC number GO terms UniProt PubMed Binding
    affinity
    1 3mt6:A (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    2 3mt6:A (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    3 3mt6:B (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    4 3mt6:B (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    5 3mt6:C (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    6 3mt6:C (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    7 3mt6:D (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    8 3mt6:D (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    9 3mt6:E (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    10 3mt6:E (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    11 3mt6:F (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    12 3mt6:F (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    13 3mt6:G (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    14 3mt6:G (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    15 3mt6:H (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    16 3mt6:H (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    17 3mt6:I (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    18 3mt6:I (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    19 3mt6:J (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    20 3mt6:J (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    21 3mt6:K (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    22 3mt6:K (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    23 3mt6:L (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    24 3mt6:L (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    25 3mt6:M (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    26 3mt6:M (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    27 3mt6:N (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    28 3mt6:N (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    29 3mt6:O (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    30 3mt6:O (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    31 3mt6:P (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    32 3mt6:P (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    33 3mt6:Q (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    34 3mt6:Q (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    35 3mt6:R (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    36 3mt6:R (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    37 3mt6:S (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    38 3mt6:S (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    39 3mt6:T (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    40 3mt6:T (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    41 3mt6:U (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    42 3mt6:U (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    43 3mt6:V (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    44 3mt6:V (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    45 3mt6:W (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    46 3mt6:W (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    47 3mt6:X (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    48 3mt6:X (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    49 3mt6:Y (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    50 3mt6:Y (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    51 3mt6:Z (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    52 3mt6:Z (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    53 3mt6:a (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    54 3mt6:a (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    55 3mt6:b (1.901) BS01 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    56 3mt6:b (1.901) BS02 peptide 3.4.21.92 GO:0004176 ... P0A6G7 20851345
    Reference:
  • Chengxin Zhang, Xi Zhang, Peter L Freddolino, and Yang Zhang. BioLiP2: an updated structure database for biologically relevent ligand-protein interactions, Nucleic Acids Research, gkad630 (2023).
  • Jianyi Yang, Ambrish Roy, and Yang Zhang. BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions, Nucleic Acids Research, 41: D1096-D1103 (2013) (download the PDF file).

    • yangzhanglabumich.edu | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218